サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：遺伝子ベクター市場- ベクター別、用途別、疾患別、エンドユーザー別、世界予測、2023年～2032年
市場調査レポート
商品コード
1305931

遺伝子ベクター市場- ベクター別、用途別、疾患別、エンドユーザー別、世界予測、2023年～2032年

Gene Vector Market - By Vector (Plasmid DNA, Adeno-Associated Viral, Retroviral), By Application (Gene Therapy, Vaccinology), By Disease (Oncology, Genetic, Infectious) By End-user (CDMO, CRO, Pharma & Biotech Companies), Global Forecast 2023-2032

出版日
ページ情報
英文 153 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
遺伝子ベクター市場- ベクター別、用途別、疾患別、エンドユーザー別、世界予測、2023年～2032年
出版日: 2023年05月15日
発行: Global Market Insights Inc.
ページ情報: 英文 153 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

遺伝子ベクターの世界市場規模は、2032年までに大幅に拡大すると見込まれます。

臨床試験の増加が業界成長の道を開くでしょう。多くの臨床試験では、遺伝子治療を化学療法、放射線療法、免疫療法などの他の治療法と組み合わせる併用療法の可能性が検討されています。このような併用療法では、複数の遺伝子ベクターを用いて異なる治療薬を投与したり、治療の相乗効果を高めたりすることが多いでしょう。臨床試験における併用療法の探求の増加は、遺伝子ベクターの需要増加に寄与しています。

遺伝子ベクター市場全体は、ベクター、用途、疾患、エンドユーザー、地域に基づいて分類されます。

ベクターに基づくと、レンチウイルスセグメントからの業界シェアは2023年から2032年まで大幅なCAGRで成長します。遺伝子治療への投資の増加は、セグメント成長に有利な機会を生み出すと思われます。レンチウイルスベクターは、標的細胞に遺伝子を導入するためのビークルとして広く使用されています。レンチウイルスベクターは、治療用遺伝子などの遺伝物質を、非分裂細胞やゆっくりと分裂する細胞を含む様々なタイプの細胞に効率的に導入することができます。この能力は、遺伝子疾患の治療に使用される遺伝子治療において、ベクターの価値を高めています。

疾患別に見ると、感染症分野の業界シェアは2023年から2032年にかけて著しいCAGRで成長します。感染症の流行が拡大していることが、遺伝子ベクターの需要を高めています。遺伝子ベクターは、感染症に対するワクチン開発に使用できます。遺伝子ベクターは特定の抗原遺伝子を宿主細胞に導入し、免疫反応と防御抗体の産生を誘発することができます。このアプローチには、細胞性免疫を含む広範な免疫反応を引き起こす能力や、新興感染症に対するワクチンを迅速に開発できる可能性などの利点があります。

エンドユーザーに基づくと、CROセグメントの産業価値は2032年まで大幅な伸びを示すと思われます。CRO数の増加がこのセグメントの成長に寄与しています。さらに、これらの組織による遺伝子治療開発への取り組みの高まりが、セグメント拡大の顕著な原動力となっています。CROは、潜在的な遺伝子治療や遺伝子ベースの治療法の安全性と有効性を評価するために、遺伝子ベクターを用いた前臨床試験を実施します。

地域別では、アジア太平洋の遺伝子ベクター市場シェアは2023年から2032年にかけて急激なCAGRで成長します。HIV/AIDSのような感染症の発生が増加していることが、この地域における遺伝子ベクターの需要を高めています。さらに、急速に拡大するヘルスケアインフラが地域の成長にさらに貢献しています。IBEFによると、2023-24年度連邦予算において、インド政府は保健家族福祉省に107億6,000万米ドルを拠出しました。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 遺伝子ベクター市場洞察

  • エコシステム分析
  • 業界への影響要因
    • 促進要因
      • 遺伝性疾患、がん、感染症の有病率の上昇
      • より高度な遺伝子編集技術の開発
      • 個別化医療への需要の高まり
      • 遺伝子治療開発のための研究開発投資の増加
      • ウイルスベクターを用いた遺伝子治療の継続的研究
    • 業界の潜在的リスク＆課題
      • 遺伝子治療の高コスト
      • 遺伝子ベクター開発の規制認可に伴う課題
  • 成長可能性分析
    • ベクタータイプ別
    • 用途別
    • 疾患別
    • エンドユーザー別
  • COVID-19インパクト分析
  • 技術的分析
  • 規制状況
    • 米国
    • 欧州
  • ポーター分析
  • PESTEL分析

第4章 競合情勢、2022年

  • イントロダクション
  • 企業マトリックス分析、2022年
  • 市場シェア分析、2022年
  • 競合のポジショニングマトリックス
  • 戦略ダッシュボード

第5章 遺伝子ベクター市場規模・予測：ベクタータイプ別

  • 主要動向：ベクタータイプ別
  • プラスミドDNA
  • レトロウイルス
  • レンチウイルス
  • アデノウイルス
  • アデノ関連ウイルス
  • その他のベクター

第6章 遺伝子ベクター市場規模・予測：用途別

  • 主要動向：用途別
  • 遺伝子治療
  • ワクチン療法
  • その他の用途

第7章 遺伝子ベクター市場規模・予測：疾患別

  • 主要動向：疾患別
  • 腫瘍学
  • 遺伝子疾患
  • 感染症
  • その他の疾患

第8章 遺伝子ベクター市場規模・予測：エンドユーザー別

  • 主要動向：エンドユーザー別
  • CDMO
  • 製薬・バイオ企業
  • 研究機関
  • CRO

第9章 遺伝子ベクター市場規模・予測：地域別

  • 主要動向：地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア・ニュージーランド
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • MEA
    • 南アフリカ
    • サウジアラビア
    • その他中東とアフリカ

第10章 企業プロファイル

  • Lonza
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Oxford Biomedica
  • Cobra Biologics
  • Novasep
  • Spark Therapeutics
  • Kaneka Eurogentec
  • Finvector Vision Therapies
  • Brammer Bio
  • Cell and Gene Therapy Catapult
  • FUJIFILM Diosynth Biotechnologies
  • uniQure N.V.
図表

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by vector type (2022)
  • TABLE 3 Market revenue, by application (2022)
  • TABLE 4 Market share, by disease2022)
  • TABLE 5 Market share, by end-user (2022)
  • TABLE 6 Market share, by region (2022)
  • TABLE 7 Global gene vector market size, by region, 2018 - 2022 (USD Million)
  • TABLE 8 Global gene vector market size, by region, 2023 - 2032 (USD Million)
  • TABLE 9 Global gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 10 Global gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 11 Global gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 12 Global gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 13 Global gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 14 Global gene vector market size, by disease 2023 - 2032 (USD Million)
  • TABLE 15 Global gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 16 Global gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 17 Industry impact forces
  • TABLE 18 Competitive benchmarking of major market players
  • TABLE 19 Competitive positioning matrix: classification criteria
  • TABLE 20 Strategic outlook matrix: classification criteria
  • TABLE 21 Plasmid DNA market size, 2018 - 2022 (USD Million)
  • TABLE 22 Plasmid DNA market size, 2023 - 2032 (USD Million)
  • TABLE 23 Adenoviral market size, 2018 - 2022 (USD Million)
  • TABLE 24 Adenoviral market size, 2023 - 2032 (USD Million)
  • TABLE 25 Adeno-associated viral market size, 2018 - 2022 (USD Million)
  • TABLE 26 Adeno-associated viral market size, 2023 - 2032 (USD Million)
  • TABLE 27 Retroviral market size, 2018 - 2022 (USD Million)
  • TABLE 28 Retroviral market size, 2023 - 2032 (USD Million)
  • TABLE 29 Lentiviral market size, 2018 - 2022 (USD Million)
  • TABLE 30 Lentiviral market size, 2023 - 2032 (USD Million)
  • TABLE 31 Other vector types market size, 2018 - 2022 (USD Million)
  • TABLE 32 Other vector types market size, 2023 - 2032 (USD Million)
  • TABLE 33 Gene therapy market size, 2018 - 2022 (USD Million)
  • TABLE 34 Gene therapy market size, 2023 - 2032 (USD Million)
  • TABLE 35 Vaccinology market size, 2018 - 2022 (USD Million)
  • TABLE 36 Vaccinology market size, 2023 - 2032 (USD Million)
  • TABLE 37 Other applications market size, 2018 - 2022 (USD Million)
  • TABLE 38 Other applications market size, 2023 - 2032 (USD Million)
  • TABLE 39 Oncology market size, 2018 - 2022 (USD Million)
  • TABLE 40 Oncology market size, 2023 - 2032 (USD Million)
  • TABLE 41 Genetic disorders market size, 2018 - 2022 (USD Million)
  • TABLE 42 Genetic disorders market size, 2023 - 2032 (USD Million)
  • TABLE 43 Infectious diseases market size, 2018 - 2022 (USD Million)
  • TABLE 44 Infectious diseases market size, 2023 - 2032 (USD Million)
  • TABLE 45 Other diseases market size, 2018 - 2022 (USD Million)
  • TABLE 46 Other diseases market size, 2023 - 2032 (USD Million)
  • TABLE 47 CDMOs market size, 2018 - 2022 (USD Million)
  • TABLE 48 CDMOs market size, 2023 - 2032 (USD Million)
  • TABLE 49 Pharmaceutical and biotechnology companies market size, 2018 - 2022 (USD Million)
  • TABLE 50 Pharmaceutical and biotechnology companies market size, 2023 - 2032 (USD Million)
  • TABLE 51 Research institutes market size, 2018 - 2022 (USD Million)
  • TABLE 52 Research institutes market size, 2023 - 2032 (USD Million)
  • TABLE 53 CROs market size, 2018 - 2022 (USD Million)
  • TABLE 54 CROs market size, 2023 - 2032 (USD Million)
  • TABLE 55 North America gene vector Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 56 North America gene vector Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 57 North America gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 58 North America gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 59 North America gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 60 North America gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 61 North America gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 62 North America gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 63 North America gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 64 North America gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 65 U.S. gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 66 U.S. gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 67 U.S. gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 68 U.S. gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 69 U.S. gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 70 U.S. gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 71 U.S. gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 72 U.S. gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 73 Canada gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 74 Canada gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 75 Canada gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 76 Canada gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 77 Canada gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 78 Canada gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 79 Canada gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 80 Canada gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 81 Europe gene vector Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 82 Europe gene vector Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 83 Europe gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 84 Europe gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 85 Europe gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 86 Europe gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 87 Europe gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 88 Europe gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 89 Europe gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 90 Europe gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 91 Germany gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 92 Germany gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 93 Germany gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 94 Germany gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 95 Germany gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 96 Germany gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 97 Germany gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 98 Germany gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 99 UK gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 100 UK gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 101 UK gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 102 UK gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 103 UK gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 104 UK gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 105 UK gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 106 UK gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 107 France gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 108 France gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 109 France gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 110 France gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 111 France gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 112 France gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 113 France gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 114 France gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 115 Italy gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 116 Italy gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 117 Italy gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 118 Italy gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 119 Italy gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 120 Italy gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 121 Italy gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 122 Italy gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 123 Spain gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 124 Spain gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 125 Spain gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 126 Spain gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 127 Spain gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 128 Spain gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 129 Spain gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 130 Spain gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 131 Rest of Europe gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 132 Rest of Europe gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 133 Rest of Europe gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 134 Rest of Europe gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 135 Rest of Europe gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 136 Rest of Europe gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 137 Rest of Europe gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 138 Rest of Europe gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 139 Asia Pacific gene vector Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 140 Asia Pacific gene vector Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 141 Asia Pacific gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 142 Asia Pacific gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 143 Asia Pacific gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 144 Asia Pacific gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 145 Asia Pacific gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 146 Asia Pacific gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 147 Asia Pacific gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 148 Asia Pacific gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 149 China gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 150 China gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 151 China gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 152 China gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 153 China gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 154 China gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 155 China gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 156 China gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 157 Japan gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 158 Japan gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 159 Japan gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 160 Japan gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 161 Japan gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 162 Japan gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 163 Japan gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 164 Japan gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 165 India gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 166 India gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 167 India gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 168 India gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 169 India gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 170 India gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 171 India gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 172 India gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 173 Australia & The Newzealand gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 174 Australia & The Newzealand gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 175 Australia & The Newzealand gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 176 Australia & The Newzealand gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 177 Australia & The Newzealand gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 178 Australia & The Newzealand gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 179 Australia & The Newzealand gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 180 Australia & The Newzealand gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 181 Rest of APAC gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 182 Rest of APAC gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 183 Rest of APAC gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 184 Rest of APAC gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 185 Rest of APAC gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 186 Rest of APAC gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 187 Rest of APAC gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 188 Rest of APAC gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 189 Latin America gene vector Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 190 Latin America gene vector Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 191 Latin America gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 192 Latin America gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 193 Latin America gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 194 Latin America gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 195 Latin America gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 196 Latin America gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 197 Latin America gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 198 Latin America gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 199 Brazil gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 200 Brazil gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 201 Brazil gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 202 Brazil gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 203 Brazil gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 204 Brazil gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 205 Brazil gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 206 Brazil gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 207 Mexico gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 208 Mexico gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 209 Mexico gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 210 Mexico gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 211 Mexico gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 212 Mexico gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 213 Mexico gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 214 Mexico gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 215 Rest of Latin America gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 216 Rest of Latin America gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 217 Rest of Latin America gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 218 Rest of Latin America gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 219 Rest of Latin America gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 220 Rest of Latin America gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 221 Rest of Latin America gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 222 Rest of Latin America gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 223 Middle East & Africa gene vector Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 224 Middle East & Africa gene vector Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 225 Middle East & Africa gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 226 Middle East & Africa gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 227 Middle East & Africa gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 228 Middle East & Africa gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 229 Middle East & Africa gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 230 Middle East & Africa gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 231 Middle East & Africa gene vector market size, by end user, 2018 - 2022 (USD Million)
  • TABLE 232 Middle East & Africa gene vector market size, by end user, 2023 - 2032 (USD Million)
  • TABLE 233 South Africa gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 234 South Africa gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 235 South Africa gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 236 South Africa gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 237 South Africa gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 238 South Africa gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 239 South Africa gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 240 South Africa gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 241 Saudi Arabia gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 242 Saudi Arabia gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 243 Saudi Arabia gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 244 Saudi Arabia gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 245 Saudi Arabia gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 246 Saudi Arabia gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 247 Saudi Arabia gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 248 Saudi Arabia gene vector market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 249 Rest of MEA gene vector market size, by vector type, 2018 - 2022 (USD Million)
  • TABLE 250 Rest of MEA gene vector market size, by vector type, 2023 - 2032 (USD Million)
  • TABLE 251 Rest of MEA gene vector market size, by application, 2018 - 2022 (USD Million)
  • TABLE 252 Rest of MEA gene vector market size, by application, 2023 - 2032 (USD Million)
  • TABLE 253 Rest of MEA gene vector market size, by disease, 2018 - 2022 (USD Million)
  • TABLE 254 Rest of MEA gene vector market size, by disease, 2023 - 2032 (USD Million)
  • TABLE 255 Rest of MEA gene vector market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 256 Rest of MEA gene vector market size, by end-user, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Gene vector industry 36 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by vector type
  • FIG 8 Growth potential analysis, by application
  • FIG 9 Growth potential analysis, by disease
  • FIG 10 Growth potential analysis, by end-use
  • FIG 11 Porter's analysis
  • FIG 12 PESTEL analysis
  • FIG 13 Competitive dashboard, 2022
  • FIG 14 Company matrix analysis, 2022
  • FIG 15 Competitive analysis of major market players, 2022
  • FIG 16 Competitive positioning matrix
  • FIG 17 Strategic outlook matrix
目次
Product Code: 5693

Global Gene Vector Market size will expand considerably through 2032. Growing number of clinical trials will pave the way for industry growth. Many clinical trials explore the potential of combination therapies, where gene therapy is combined with other treatment modalities such as chemotherapy, radiation therapy, or immunotherapy. These combination approaches often involve the use of multiple gene vectors to deliver different therapeutic agents or enhance treatment synergies. The increasing exploration of combination therapies in clinical trials contributes to the higher demand for gene vectors.

The overall gene vector market is classified based on vector, application, diseases, end-user, and region.

Based on the vector, industry share from the lentiviral segment will grow at a substantial CAGR from 2023 to 2032. Increasing investment in gene therapy will generate lucrative opportunities for segment growth. Lentiviral vectors are widely used as vehicles for delivering genes into target cells. They can efficiently transfer genetic material, such as therapeutic genes, to a range of cell types, including non-dividing or slowly dividing cells. This ability makes them valuable in gene therapy, where they are used to treat genetic disorders.

Based on diseases, industry share from the infectious disease segment will grow at a significant CAGR from 2023 to 2032. Growing prevalence of infectious diseases has increased the demand for gene vectors. Gene vectors can be used to develop vaccines against infectious diseases. They can deliver specific antigen genes into host cells, triggering an immune response and the production of protective antibodies. This approach offers advantages such as the ability to generate a broad immune response, including cellular immunity, and the potential to rapidly develop vaccines for emerging infectious diseases.

Based on the end-user, industry value from the CROs segment will register significant gains through 2032. Increasing number of CROs is contributing to segment growth. Moreover, rising efforts by these organizations toward the development of gene therapies are further creating a notable impetus for segment expansion. CROs conduct preclinical studies using gene vectors to assess the safety and efficacy of potential gene therapies or gene-based treatments.

Regionally, the Asia Pacific gene vector market share will grow at an exponential CAGR from 2023 to 2032. Growing occurrence of infectious disorders such as HIV/AIDS has increased the demand for gene vectors in the region. Moreover, rapidly expanding healthcare infrastructure is further contributing to regional growth. As per IBEF, in the Union Budget 2023-24, the government of India awarded USD 10.76 billion to the Ministry of Health and Family Welfare.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data Sources
    • 1.4.1 Secondary
      • 1.4.1.1 Paid sources
      • 1.4.1.2 Public sources
    • 1.4.2 Primary

Chapter 2 Executive Summary

  • 2.1 Gene vector 360 degree synopsis, 2018 - 2032
  • 2.2 Business trends
  • 2.3 Vector type trends
  • 2.4 Application trends
  • 2.5 Disease trends
  • 2.6 End user trends

Chapter 3 Gene Vector Market Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of genetic disorders, cancer, and infectious diseases
      • 3.2.1.2 Development of more advanced gene editing technologies
      • 3.2.1.3 Increasing demand for personalized medicine
      • 3.2.1.4 Increase in R&D investments for the development of gene therapy
      • 3.2.1.5 Ongoing research into viral vector-based gene therapies
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of gene therapies
      • 3.2.2.2 Challenges associated with regulatory approval of gene vectors development
  • 3.3 Growth potential analysis
    • 3.3.1 By vector type
    • 3.3.2 By application
    • 3.3.3 By disease
    • 3.3.4 By end user
  • 3.4 COVID- 19 impact analysis
  • 3.5 Technological analysis
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Market share analysis , 2022
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Gene Vector Market Size and Forecast, By Vector Type (USD Million)

  • 5.1 Key trends, by vector type
  • 5.2 Plasmid DNA
  • 5.3 Retroviral
  • 5.4 Lentiviral
  • 5.5 Adenoviral
  • 5.6 Adeno-associated viral
  • 5.7 Other vector types

Chapter 6 Gene Vector Market Size and Forecast, By Application (USD Million)

  • 6.1 Key trends, by application
  • 6.2 Gene therapy
  • 6.3 Vaccinology
  • 6.4 Other applications

Chapter 7 Gene Vector Market Size and Forecast, By Disease (USD Million)

  • 7.1 Key trends, by disease
  • 7.2 Oncology
  • 7.3 Genetic disorders
  • 7.4 Infectious diseases
  • 7.5 Other diseases

Chapter 8 Gene Vector Market Size and Forecast, By End-user (USD Million)

  • 8.1 Key trends, by end-user
  • 8.2 CDMOs
  • 8.3 Pharmaceutical and biotechnology companies
  • 8.4 Research institutes
  • 8.5 CROs

Chapter 9 Gene Vector Market Size and Forecast, By Region (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia and New Zealand
    • 9.4.5 Rest of Asia pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 MEA
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

  • 10.1 Lonza
  • 10.2 Merck KGaA
  • 10.3 Thermo Fisher Scientific Inc.
  • 10.4 Oxford Biomedica
  • 10.5 Cobra Biologics
  • 10.6 Novasep
  • 10.7 Spark Therapeutics
  • 10.8 Kaneka Eurogentec
  • 10.9 Finvector Vision Therapies
  • 10.10 Brammer Bio
  • 10.11 Cell and Gene Therapy Catapult
  • 10.12 FUJIFILM Diosynth Biotechnologies
  • 10.13 uniQure N.V.